Executive Briefing for Gallos
Entry into Upscale Wines
|
Goizueta Partners Consulting
Corporation was hired by Ernest Gallo to evaluate Gallos
entry into the upscale wine market. Accordingly, this executive
briefing analyzes how Gallo manages industry structure to enhance
their market position and how this may hinder entry into the
upscale market. It closes with a focus on how they can leverage
these attributes to break into the up-scale wine market.
Gallo has a Very
Strong Position in the Low Priced Industry Segment
The following is a summary of Gallos
current industry position in the low price segment of the wine
industry.
Potential Entrants
HIGH Entry
Barriers Profit Impact is POSITIVE
- Gallo has coalitions
with distributors that prevent new entrants.
- Low price/ margins
driven by scale economies
- Gallo responds
aggressively to entrants
- Knowledge is hard to
imitate.
- Private ownership
hinders entry.
|

Supplier Power
LOW Supplier
Power
Profit Impact is POSITIVE
- Vineyards: Gallo
outsources to get market prices from small
fragmented growers. Gallo cant be held up
due to their storage capacity. Growers can't
forward integrate since Gallo owns distribution.
Through R&D, they know growing better than
suppliers.
|

|
Industry Rivalry
LOW Rivalry
Profit Impact is POSITIVE
- Size and scale relative
to competitors (3-5 times larger) offers a real
cost advantage
- Marketing knowledge and
distribution channels is hard to imitate.
- Vertical integration
means they have more control over suppliers than
competitors.
|

|
Customer/Buyer Power
LOW Buyer Power
Profit Impact is POSITIVE
- Distributors:
Gallo owns many distribution outlets. Others are
trained & made exclusive representatives. Low
performers are cut.
- Customers: Gallo
creates brand loyalty by advertising direct to
customers (raising switching costs).
|

Substitutes for Low Priced Wine
MODERATE Threat
of Substitutes Profit Impact is POSITIVE
- Expensive wines
- Other inexpensive
alcoholic beverages (Beer, etc.)
- Mixed drinks
- Other beverages, soft
drinks, juices, milk, etc.
|
In sum, Gallo has a very strong
position in the low-cost segment of the wine industry. Here, they
face few competitors that can match their scale and expertise. In
fact, Gallo is 3-5 times the size of their nearest competitor. In
terms of advertising expenditures, Almaden, Paul Masson,
Inglenook, and Sutter Home form are the most significant
competitors. However, Gallos $15 million advertising budget
outstrips them by 4 to 8 times. This creates very strong brand
recognition and Gallo is able to dominate shelf space through
exclusive arrangements and owning many of the distribution
channels.
Their power over suppliers and
distributors grants them leverage over other players to engage in
price competition extremely effectively and aggressively.
Gallos
Position is a Barrier to Entry into Upscale Markets
While these advantages grant Gallo a
very strong position in the low-priced segment, they also serve
as powerful barriers for their entry into the moderate or upscale
segments of the wine market. The following points illustrate the
dilemmas:
- The reputation as a low cost
producer creates an image problem for the upscale market.
Gallo's brand recognition actually works against their
strategy. Earnest & Julio are too proud to drop their
name from the product.
- The distribution channels
differ slightly for the upscale market.
- Gallos technology
advantage is geared toward volume rather than quality.
All of their structures are oriented toward low costs and
some aspects of quality have been sacrificed.
- Size and scale are not much of
an advantage in the high end of the market so there are
many players and Gallo is not well suited to this type of
competition.
Recommendations
for How Gallo Can Enter the Upscale Market
Based on this analysis, we make the
following recommendations for how Gallo can overcome these
barriers and enter the upscale market:
- Develop a new brand name to
avoid association with Gallos low-priced reputation
Benefits
|
Barriers
|
- Avoids the association
with the Gallo name
- Leverages on Gallos
marketing expertise
|
Ernest and Julio want
their name associated with quality.
|
- Identify ways to introduce
technology into high quality wine production:
Benefits
|
Barriers
|
- Leverages on Gallos
technology advantage in the low cost segment to
improve quality & consistency.
|
Wine connoisseurs are
very cautious about new technologies and may snub
the products even if they are high quality.
|
- Identify new distribution
channels and use their muscle in existing channels for
the low priced products to get space for the upscale
products.
Benefits
|
Barriers
|
- Extends the
distribution advantage from low priced wines and
pushes to find new outlets.
|
Gallo may not have as
much of an advantage in new distribution channels.
|
- Hire an outside firm to market
the new brand using different channels and promotions
than are used for other Gallo products.
Benefits
|
Barriers
|
- This will create
awareness of the new brand independent of Gallos
name.
|
This does not draw on
the marketing expertise that has served Gallo for
many years (it has been handled internally).
|
Executive Briefing on
Monsanto s Diversification Strategy
|
Goizueta Partners Consulting
Corporation was hired by Monsanto shareholders to assess Monsantos
diversification strategy. Accordingly, this executive briefing
analyzes why Monsanto failed to create value across lines of
business when it diversified from chemicals into biotechnology.
It closes with recommendations of steps they can take now to
create value across the remaining business units (plant
agriculture, animal husbandry, and pharmaceuticals).
Opportunities to
Create Value Through Diversification
There are a limited number of
strategies available for value creation across lines of business.
The following table lists the primary methods, specific
opportunities at Monsanto and finally the barriers that
ultimately prevented value creation.
Value
Creation Strategy
|
Opportunities
to Create Value
|
Barriers
to Creating Value
|
| Operational
Economies of Scope |
- The chemical and
biotechnology businesses could share distribution
channels in some markets.
- Sales & marketing
could be combined.
- The procedures for
regulatory approval may be common to the two
businesses.
|
The markets &
customers do not fully overlap.
The combined functions
may not actually be more efficient (e.g., there
may not be scale economies).
The distinct cultures (cost
v. differentiation) may make it hard to combine
the functions.
|
| Transferring
Core Competencies |
- Monsanto may be viewed
as having a core competency in research.
- They are also effective
at working with universities (e.g., Washington
University) to license discoveries.
|
The science of
biotechnology is fundamentally different from
chemicals.
The cost-focused
culture of chemicals is not compatible with the
cutting edge science required in biotechnology.
|
| Vertical
Integration |
- There may be some
opportunities to use products from chemicals as
inputs for biotechnology research or products.
|
The chemicals are
commodities its not clear why internal
suppliers would be more efficient.
|
| Internal
Capital Markets |
- Monsanto could funnel
cash from the chemicals business (cow) to the
biotechnology business.
|
Chemicals isnt
generating huge amounts of cash.
Its not clear why this
would be more efficient than external capital
markets.
|
| Restructuring/Discipline |
- They are certainly not
acquiring biotechnology companies to bust them up
or manage them more efficiently.
|
If they tried, the key
human assets would leave the target and the
restructured target would be worth less.
|
| Acquisition
Competence |
- Their biotechnology
knowledge helps them identify bargains others
miss.
|
This only applies after
Monsanto acquired the knowledge.
It doesnt explain
synergies between chemicals and life sciences.
|
Monsanto sought to diversify away
from the pure chemicals business because it is fundamentally low
margin cost-based competition. Biotechnology was particularly
attractive since the products and technology are proprietary. In
other words, it was differentiation-based and allowed for higher
margins.
However, there are many
differentiation-based businesses they could have entered. They
chose biotechnology because they saw it as complementary to their
existing chemical business. Monsanto might have seen some
opportunities initially to create value with its core competence
in science or by combining marketing and distribution channels.
Why Monsanto
Failed to Create Value Across Lines of Business
As the table illustrates, Monsanto
faced some serious and unanticipated barriers to creating value
across businesses. These are summarized below:
- The cultures for the cost-based
chemicals business and the differentiation-based
biotechnology business are incompatible. Employees on the
two sides of the business became adversaries.
- A competency in conducting
applied research (chemicals) differs from a competency in
basic research (biotechnology). The former is best
organized by market to assure that the innovations have
applications. The later is best organized by scientific
discipline to facilitate knowledge creation.
- The management team at the
corporate headquarters did not actively seek out
opportunities for the businesses to interact they
were more concerned with how to build the biotechnology
capability.
Recommendations
for How Monsanto Can Create Value
Based on this analysis, we make the
following recommendations for how Monsanto can create value. In
general, Monsanto can create value by separating the businesses.
That is, the two businesses are clearly not creating value and
may be holding each other back (e.g., destroying value):
- Sell the chemicals division to
DOW or some other competitor:
Benefits
|
Barriers
|
- Generates cash
- Eliminates the drain on
the biotechnology business.
|
Individuals have viewed
DOW as an "arch enemy" and this might
not be palatable.
|
- Spin off the chemicals division
as separate entity:
Benefits
|
Barriers
|
- Eliminates the drain on
the biotechnology business.
- Will be seen as
granting them their autonomy.
|
It doesnt
immediately fulfill the cash needs as well.
How will the assets and
liabilities be split?
|
Action Steps
The following are some initial
action steps that should be taken to resolve this issue:
| Action
Steps |
Who
|
When
|
| 1.
Meet with investment bankers to identify cash flow
implications |
CFO |
|
| 2.
Name a task force to recommend how the assets &
liabilities will be distributed |
Chairman |
|
| 3.
Meet with corporate attorneys to discuss fiduciary
responsibilities |
Chairman |
|
| 4.
Begin drafting a letter to shareholders contact
major shareholders personally |
Chairman |
|